Keeping you up to date with all the Lymphoma Team news

The Lymphoma Research Team are excited to be the only UK site selected to work on a Global Real-World Evidence study with pharmaceutical company Celgene.

We are pleased to announce that Professor Radford has been appointed President of Lymphoma Action which is the UK's only charity dedicated to lymphoma. 

Our team have always worked closely with Lymphoma Action so we can be sure that Professor Radford's appointment will only bring further benefits for patients, especially for informing and supporting those affected by lymphoma, increasing awareness and improving standard of care through education and research.

Congratulations to Professor Radford and who has been awarded a fellowship by the Academy of Medical Sciences for excellence of his science, his contribution to medicine and society and range of his achievements.

Professor Rob Bristow, Director of the Manchester Cancer Research Centre and Chief Academic officer was also selected for the prestigious award with himself and Professor Radford being the only two new fellows from the North West and both work here at the Christie.






In April we proudly supported Maggie Harris, Jane Gibson, Caroline Long (Hamer) and Louise Garlic as they raced in their relay for Lymphoma Action at the Greater Manchester marathon.

They did amazingly well and managed to raise a massive £1,000 for the charity!

Take a look at photos from the event below.

Well done ladies!

In April the lymphoma clinical trial team held our second charity cake sale, this time to raise money for charity Chernoble Children's project.

This local charity fundraises throughout the year in order to bring a group of children in remission from cancer for an action-packed holiday in the Peak District. The trip is proven to boost their immune systems, helping them stay healthy in the future.

Unfortunately despite the Chernobyl Nuclear Disaster occurring in 1986, children in Belarus are still suffering the after effects of radiation.

The team managed to raise a fantastic amount of £93 from the cake sale!

Well done to all our brilliant home bakers and thank you to anyone who donated.

Our next cake sale will be to raise money for charity Meningitis Now. Watch this space!

As part of the Christie celebrating the 70th anniversary of the NHS, for 70 days 70 individuals have been nominated by staff or patients as a 'Christie hero'.

We are pleased to announce that our very own Jane Gibson-Advanced Nurse Practitioner was nominated by Nigel Billings, a patient at The Christie. Nigel said “Jane was my Lymphoma Nurse and my first point of contact. Her support has helped me through this chapter of my life. She is a very special person to me.”

Within the last 12 months Jane has transitioned from a Clinical Nurse Specialist to an Advanced Nurse Practitioner and is excelling in her new role within the team.

Well done Jane, very well deserved!

Professor Tim Illidge, Professor of Targeted Therapy and Oncology and three senior researchers based at The Christie have won prestigious honours from the Royal College of Radiologists (RCR).

Professor Illidge, received the RCR Gold Medal, the highest honour the college can award and made in recognition of his ‘enormous national and international contribution to clinical oncology’. 

Prof Illidge is the first Manchester-based recipient of the award since Professor Ralston Paterson in 1966. Prof Paterson was a world-leading authority on treating cancer with radiotherapy and gave his name to the building on Wilmslow Road in Withington which was badly damaged by fire in April 2017.

Prof Illidge, who lives in Disley, is head of the division of cancer services at The University of Manchester and oversees a large number of academic staff. He said: “The medal came as a tremendous surprise but of course I’m really honoured and humbled to receive it.

“Awards such as this are always the result of a big team effort so it’s recognition of all the hard work my colleagues at The University of Manchester and The Christie have put in. I am thrilled that three of us from Manchester were honoured at the awards ceremony which shows that we are recognised as being at the forefront of clinical oncology in the UK.

“There have been very few oncologists to have won the gold medal in the last 50 years and it is great that Manchester has got this recognition again.”

The awards took place at the RCR’s annual Admission of Fellows ceremony at Westminster Central Hall in London.

The lymphoma team congratulate Tim and his colleagues for this fantastic achievement!

In June the clinical trial co-ordinators held a cake sale to raise money for the Alzheimer’s Society.

They raised £65.00 which with gift aid will come to £81.25!

As it was such a success we have decided to hold a charity cake sale every couple of months for different charities of choice.

Well done to everyone who baked the extremely tasty cakes and thank you to each member of staff who donated money for a brilliant cause!


In March the lymphoma team were the first in the UK to recruit two new patients with follicular lymphoma into the clinical trial ReBel. This new trial is to see how well lenalidomide and rituximab work with or without bendamustine in people with relapsed follicular lymphoma. 

Clinical trial patient Nigel and his wife Julie presented Dr Kim Linton with a beautiful hand crafted advent calendar for The Lymphoma Team just in time for advent!

We are delighted with the thoughtful gift which Julie has been making since August and it will have pride of place in our office for everyone to enjoy. Thank you to Nigel and Julie and a Merry Christmas to all our patients and their families!

In November Professor Radford was announced as winner of the ‘Lifetime Achievement’ category at the Greater Manchester Clinical Research Awards. He has led many practice-changing trials in lymphoma and is an internationally recognised leader in the field so as a team we are extremely pleased he was recognised in this way.

Professor Radford was humbled and regarded the award as ‘flying the flag for all the high impact clinical research going on at the Christie and our partners, including other trusts, The University of Manchester and Cancer Research UK'.

In July we became the first site in the world to open the new CTCL chart review study. This study looks at real-world treatment patterns and outcomes in relapsed/refractory cutaneous T-cell lymphoma (CTCL).

We give a warm welcome to our new research nurse Chiara Dallatorre who started on the team in June 2017. Chiara is an experienced haematology nurse who has previously worked for Blackpool Victoria Hospital and we are sure she will make a great addition to our research team.


In January Professor Radford and Dr Gibb were named as lead authors on a Pfizer abstract to be presented at the International Conference on Malignant Lymphoma in Lugano, Switzerland in June 2017.

Professor John Radford has recently been invited to join the editorial board of the AOL (Annals of Lymphoma) which is a rising high quality electronic journal, openly distributed worldwide relating to lymphoma research.

  • We are very happy to announce that on the 17th November our team were named winners of Research Team Of The Year at the Greater Manchester Clinical Research Awards 2016!

  • On the 22nd of October 2016 The BREVITY trial along with our other projects ADAPT and BARD were presented at ISHL (International Symposium of Hodgkin lymphoma) in Cologne by Professor Radford and Dr Adam Gibb.

  • In November our team was the 1st recruiter in the UK for the SGN35.023 trial. This study looks at comparing treatment with the combination of rituximab and bendamustine chemotherapy against the combination of rituximab and bendamustine with added brentuximab.

  • The Lymphoma Group were the 1st recruiter in the world for the BI 1206 CRUK clinical trial. BI 1206 is a type of biological therapy called an antibody. It works by recognising and attaching to a particular protein called CD32b. This protein is found on some cancer cells in some types of lymphoma and leukaemia. Laboratory studies show that by blocking the CD32b protein BI 1206 could stop cancer cells from growing and dividing. Researchers want to find out if BI 1206 can help people with B cell non Hodgkin lymphoma and chronic lymphocytic leukaemia (CLL).

  • Our team has now been re-designated as a Bloodwise TAP (Trials Acceleration Programme) Centre, making us 1 of 13 centres nationally.

  • Our clinical research nurse Andrea Whitmore successfully completed a skin biopsy course and will now be carrying out biopsies for our lymphoma patients when required. This will be highly beneficial as it prevents the need to use other services, reduces patient waiting times and will be more convenient to our patients overall. Well done Andrea!

  • The Lymphoma Group were the UK's top recruiter for the Polatuzumab Vedotin trial (GO29365). This study was looking at Polatuzumab Vedotin in combination with Bendamustine and Rituximab or Obinutuzumab.

  • The Lymphoma Group were the UK's first recruiter and second global recruiter for the JAVELIN Hodgkin lymphoma trial which is a study looking at Avelumab in patients with previously treated advanced stage Hodgkin lymphoma.